Literature DB >> 8063048

Effect of insulin-like growth factor-I therapy on erythropoetin concentrations in extreme insulin resistance.

J D Quin, J P Miell, K Smith, D Gordon, J Strachan, J B Dick, A C MacCuish.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8063048     DOI： 10.1007/bf00408484

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Acute response to recombinant insulin-like growth factor I in a patient with Mendenhall's syndrome.

Authors:  J D Quin; B M Fisher; K R Paterson; A Inoue; G H Beastall; A C MacCuish
Journal:  N Engl J Med       Date:  1990-11-15       Impact factor: 91.245

2.  Growth-stimulating effects of recombinant human growth hormone in children with end-stage renal disease.

Authors:  B Tönshoff; O Mehis; U Heinrich; W F Blum; M B Ranke; A Schauer
Journal:  J Pediatr       Date:  1990-04       Impact factor: 4.406

3.  Trial of insulinlike growth factor I therapy for patients with extreme insulin resistance syndromes.

Authors:  H Kuzuya; N Matsuura; M Sakamoto; H Makino; Y Sakamoto; T Kadowaki; Y Suzuki; M Kobayashi; Y Akazawa; M Nomura
Journal:  Diabetes       Date:  1993-05       Impact factor: 9.461

4.  Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats.

Authors:  A Kurtz; J Zapf; K U Eckardt; G Clemons; E R Froesch; C Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-10       Impact factor: 11.205

5.  Improvement of lipid profile in type 2 (non-insulin-dependent) diabetes mellitus by insulin-like growth factor I.

Authors:  P D Zenobi; P Holzmann; Y Glatz; W F Riesen; E R Froesch
Journal:  Diabetologia       Date:  1993-05       Impact factor: 10.122

6.  Insulin-like growth factor I: a modulator of erythropoiesis in uraemic patients?

Authors:  P Ureña; A Bonnardeaux; K U Eckardt; A Kurtz; T B Drüeke
Journal:  Nephrol Dial Transplant       Date:  1992       Impact factor: 5.992
  6 in total
  1 in total

1.  Effect of long-term treatment with recombinant human growth hormone on erythropoietin secretion in an anemic patient with panhypopituitarism.

Authors:  M Sohmiya; Y Kato
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.